Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-303 vs Vehicle in Cataract Surgery
NCT01808547Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- May 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in ocular inflammation comparing ISV-303 with Vehicle (2 arms). Primary endpoint: Proportion of subjects with anterior chamber cell (ACC) Grade of 0 at 15 days. Started May 2013; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01808547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808547.